Effect of soy protein supplementation in patients with chronic hepatitis C: A randomized clinical trial

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

435

HTML

3080

Figures (1-3)

275

Tables (1-8)

218

Sum=4008

May 14, 2012 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 14, 2012; 18(18): 2203-2211
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2203

Full Size Figure Download Figure

Figure 2 Prevalence of hepatic steatosis condition after intervention for those who begin with hepatic steatosis.

Citation: Oliveira LP, Jesus RP, Boulhosa RS, Mendes CMC, Gnoatto MC, Lemaire DC, Toralles MBP, Cavalcante LN, Lyra AC, Lyra LG. Effect of soy protein supplementation in patients with chronic hepatitis C: A randomized clinical trial. World J Gastroenterol 2012; 18(18): 2203-2211
URL: https://www.wjgnet.com/1007-9327/full/v18/i18/2203.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i18.2203